These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27356740)

  • 1. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
    Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
    Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted DNA demethylation of the
    Gallego-Bartolomé J; Gardiner J; Liu W; Papikian A; Ghoshal B; Kuo HY; Zhao JM; Segal DJ; Jacobsen SE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2125-E2134. PubMed ID: 29444862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Fidelity CRISPR/Cas9-Based Gene-Specific Hydroxymethylation.
    Xu X; Zeisberg EM
    Methods Mol Biol; 2021; 2272():195-206. PubMed ID: 34009615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Targeting of TET Activity for Targeted Demethylation Using CRISPR/Cas9.
    Nguyen TV; Lister R
    Methods Mol Biol; 2021; 2272():181-194. PubMed ID: 34009614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
    Umeh-Garcia M; O'Geen H; Simion C; Gephart MH; Segal DJ; Sweeney CA
    Br J Cancer; 2022 Aug; 127(3):436-448. PubMed ID: 35440669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.
    Wilk C; Effenberg L; Abberger H; Steenpass L; Hansen W; Zeschnigk M; Kirschning C; Buer J; Kehrmann J
    Cell Immunol; 2022 Jan; 371():104471. PubMed ID: 34954490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
    Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
    Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
    Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
    Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions.
    Morita S; Noguchi H; Horii T; Nakabayashi K; Kimura M; Okamura K; Sakai A; Nakashima H; Hata K; Nakashima K; Hatada I
    Nat Biotechnol; 2016 Oct; 34(10):1060-1065. PubMed ID: 27571369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.
    Mizuguchi Y; Saiki Y; Horii A; Fukushige S
    Cancer Med; 2016 Sep; 5(9):2522-33. PubMed ID: 27457352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized Protocol for the Regulation of DNA Methylation and Gene Expression Using Modified dCas9-SunTag Platforms.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2024; 2842():155-165. PubMed ID: 39012594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmable targeted epigenetic editing using CRISPR system in Bombyx mori.
    Liu Y; Ma S; Chang J; Zhang T; Chen X; Liang Y; Xia Q
    Insect Biochem Mol Biol; 2019 Jul; 110():105-111. PubMed ID: 31022512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
    Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
    Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9-SunTag Platform.
    Morita S; Horii T; Kimura M; Hatada I
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9.
    Sapozhnikov DM; Szyf M
    Nat Commun; 2021 Sep; 12(1):5711. PubMed ID: 34588447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways.
    Taghbalout A; Du M; Jillette N; Rosikiewicz W; Rath A; Heinen CD; Li S; Cheng AW
    Nat Commun; 2019 Sep; 10(1):4296. PubMed ID: 31541098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-mediated promoter de/methylation technologies for gene regulation.
    Sung CK; Yim H
    Arch Pharm Res; 2020 Jul; 43(7):705-713. PubMed ID: 32725389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.
    Li M; Tang Y; Li Q; Xiao M; Yang Y; Wang Y
    Oncogene; 2019 May; 38(18):3488-3503. PubMed ID: 30651599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.